Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody–drug conjugates

帕妥珠单抗 点突变 错义突变 突变 药物设计 突变体 化学 癌症研究 遗传学 生物 生物化学 曲妥珠单抗 癌症 基因 乳腺癌
作者
Xuefei Bai,Lingyi Xu,Zhe Wang,Xinlei Zhuang,Jiangtao Ning,Yanping Sun,Haibin Wang,Yugang Guo,Yingchun Xu,Jiangtao Guo,Shuqing Chen,Liqiang Pan
出处
期刊:Proceedings of the National Academy of Sciences of the United States of America [National Academy of Sciences]
卷期号:122 (1)
标识
DOI:10.1073/pnas.2413686122
摘要

Recurrent missense mutations in the human epidermal growth factor receptor 2 (HER2) have been identified across various human cancers. Among these mutations, the active S310F mutation in the HER2 extracellular domain stands out as not only oncogenic but also confers resistance to pertuzumab, an antibody drug widely used in clinical cancer therapy, by impeding its binding. In this study, we have successfully employed computational-aided rational design to undertake directed evolution of pertuzumab, resulting in the creation of an evolved pertuzumab variant named Ptz-SA. This variant, with only two mutations (T30S/D31A) located on its heavy chain, effectively reinstates binding to the mutated antigen, at the expense of a 35-fold reduction in binding affinity to HER2 (S310F) compared to the wild-type pair. Subsequently, Ptz-SA demonstrates potent killing capacity through antigen-dependent cytotoxicity. Moreover, upon engineering Ptz-SA into antibody–drug conjugates, such as Ptz-SA-MMAE, it manifests notable in vitro and in vivo antitumor efficacy by efficiently delivering cytotoxic payload into tumor cells expressing HER2 (S310F). Cryoelectron microscopy studies elucidate the molecular mechanism underlying the restored binding ability of Ptz-SA toward the S310F mutation. The steric hindrance induced by the S310F mutation is efficiently circumvented by the T30S and D31A mutations, which provides adequate space to accommodate the larger phenylalanine. Additionally, Ptz-SA also exhibits binding capacity to HER2 (S310Y), another mutation occurring at the S310 site of HER2 with high frequency. The computational-aided evolution of pertuzumab provides an alternative strategy for overcoming point mutation-mediated resistance to therapeutic antibodies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
桃tao发布了新的文献求助10
3秒前
4秒前
好滴捏发布了新的文献求助10
4秒前
lm完成签到,获得积分10
4秒前
浮浮世世发布了新的文献求助10
4秒前
linn发布了新的文献求助10
4秒前
科研2121完成签到,获得积分10
5秒前
城南花已开完成签到,获得积分20
6秒前
我是老大应助周em12_采纳,获得10
7秒前
terence完成签到,获得积分0
7秒前
suger完成签到,获得积分10
8秒前
科研2121发布了新的文献求助10
9秒前
Stardust发布了新的文献求助10
9秒前
浮浮世世完成签到,获得积分10
9秒前
10秒前
完美世界应助非一采纳,获得10
10秒前
果果完成签到,获得积分10
14秒前
万能图书馆应助好滴捏采纳,获得10
14秒前
14秒前
14秒前
科目三应助拼搏一曲采纳,获得10
14秒前
量子星尘发布了新的文献求助10
16秒前
17秒前
852应助lemonkane采纳,获得20
17秒前
思源应助linn采纳,获得10
18秒前
lilila666发布了新的文献求助10
18秒前
21秒前
张钦奎发布了新的文献求助10
21秒前
Jem完成签到,获得积分10
21秒前
悦悦应助天真的冬瓜采纳,获得10
22秒前
猪猪侠完成签到,获得积分10
24秒前
25秒前
zyj完成签到,获得积分10
26秒前
26秒前
啦啦啦发布了新的文献求助10
27秒前
28秒前
28秒前
天真的冬瓜完成签到,获得积分10
29秒前
31秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989378
求助须知:如何正确求助?哪些是违规求助? 3531442
关于积分的说明 11254002
捐赠科研通 3270126
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173